Health economist with 16 years of experience in the pharmaceutical industry and consulting. Extensive pharmaceutical reimbursement and health economic experience gained working in Europe and international markets, having held global and regional positions for the pharmaceutical industry and as strategy consultant. Produced diversified health economic analyses for developed and developing countries with over 30 peer-reviewed articles and abstracts published. His research focuses on the development and implementation of novel analytic frameworks that assess the public economic effects of healthcare investments.